A December 2021 simulation modeling study of 19.45 million people published in JAMA Network Open found that when introducing respiratory syncytial virus (RSV) from external sources to mimic the relaxation of COVID-19 pandemic precautions in the United States, hospitalization rates were expected to increase between the spring and summer of 2021.

Clarissa Chan, PharmD

Trending Topics in Health-System Pharmacy

APhA Staff

In early January 2022, FDA released a Drug Safety Communication surrounding dental problems following use of buccal and sublingual buprenorphine products for the treatment of pain and opioid use disorder.

Hailey Mook, PharmD

In the United States, oral anticoagulant use has increased by 54% since 2012, particularly with the use of newer direct oral anticoagulants (DOACs). Unfortunately, among clinicians in certain settings knowledge gaps persist concerning the safety of these therapies, including the risk of acute infection.

Corey Diamond, PharmD

One in five patients continue to use opioids for longer than 3 months after a total hip or knee arthroplasty, according to results of a new analysis published in the American Journal of Health-System Pharmacists (AJHP).

Maria G. Tanzi, PharmD